drugset / Trial / NCT00133341

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

NCT00133341

Phase 2 Completed 60 enrolled Mekos Laboratories AS
Non-randomizedSingle-groupDouble-blindDiagnostic

Summary

It is the purpose of this study to determine the concentration of 3 allergens (goldnatriumthiosulphate, methyldibromoglutharonitrile \[MDBGN\], parthenolide) for diagnosing allergic contact dermatitis.

Timeline

Start
2005-04
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject goldnatriumthiosulphate Unknown Topical
Subject methyldibromoglutharonitrile Unknown Topical
Subject parthenolide Small molecule Topical